We are aware that our case series is small to draw definitive conclusions, however, our findings are in line with previous works, showing that in-situ carcinomas are the primary cause of NAC involvement and that these DCIS frequently overexpress HER2 [28–30, 25]. The gene discussed is ERBB2; the disease is in situ carcinoma.